Alzamend Neuro

Dublin, Ireland, August 20, 2026 Keenova Therapeutics plc has announced that the first patient has been enrolled and dosed...

Atlanta, Georgia, August 20, 2026 Alzamend Neuro, Inc. has announced that data from its Phase 1/2A clinical trial of...

ATLANTA, United States, April 7, 2026 Alzamend Neuro, Inc. announced encouraging pharmacodynamic data from its Phase II clinical trial...